Afghanistan vs Gambia: Previously treated cases tested for RR-/MDR-TB
Afghanistan
100.0%
in 2024
Gambia
100.0%
in 2024
Afghanistan rank
1st
Gambia rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Afghanistan
- Gambia
How they compare
Afghanistan currently reports 100.0% against 100.0% in Gambia, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2012 it was Afghanistan ahead.
Afghanistan ranks 1st and Gambia ranks 1st of 180 countries.
Across the 2 decades both report, Afghanistan averaged higher in 1 and Gambia in 1.
Head to head by decade
| Decade | Afghanistan | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 38.4% | 53.6% | 15.2% | Gambia |
| 2020s | 89.0% | 86.8% | 2.2% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Afghanistan or Gambia?
- Afghanistan, at 100.0% against 100.0% in Gambia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Afghanistan and Gambia?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Gambia?
- 11 years are reported by both, from 2012 to 2024.
- How do Afghanistan and Gambia rank globally for previously treated cases tested for rr-/mdr-tb?
- Afghanistan ranks 1st and Gambia ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.